{"id":11481,"date":"2026-02-18T17:56:25","date_gmt":"2026-02-18T17:56:25","guid":{"rendered":"https:\/\/medical-article.com\/?p=11481"},"modified":"2026-02-18T17:56:25","modified_gmt":"2026-02-18T17:56:25","slug":"eli-lilly-joins-chase-for-hot-inflammation-target-paying-100m-for-rights-to-csl-drug","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=11481","title":{"rendered":"Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug"},"content":{"rendered":"<p><a href=\"https:\/\/medcitynews.com\/2026\/02\/eli-lilly-csl-inflammation-cardiovascular-il-6-clazakizumab-cslly-lly\/\"><\/a><\/p>\n<p>CSL Limited retain rights to clazakizumab in end-stage kidney disease. Eli Lilly gets rights to the the IL-6-blocking antibody in other indications that could put it in competition with Novo Nordisk and Novartis. <\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2026\/02\/eli-lilly-csl-inflammation-cardiovascular-il-6-clazakizumab-cslly-lly\/\">Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug<\/a> appeared first on <a href=\"https:\/\/medcitynews.com\/\">MedCity News<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>CSL Limited retain rights to clazakizumab in end-stage kidney disease. Eli Lilly gets rights to the the IL-6-blocking antibody in other indications that could put it in competition with Novo Nordisk and Novartis. The post Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug appeared first on MedCity News.<\/p>\n","protected":false},"author":0,"featured_media":11482,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-11481","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/11481"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11481"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/11481\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/media\/11482"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11481"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11481"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}